Refractory Bone or Joint Infections

Clinical trial pipeline · Data from ClinicalTrials.gov

Total trials

Actively recruiting

Phase 3 trials

Completed

To evaluate the safety and effectiveness of oral sodium fusidate (CEM-102) as chronic antibiotic for the treatment of bone or joint infections.